Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessUBS Downgrades Reinsurance Group of America to Neutral on Execution Risks and...

UBS Downgrades Reinsurance Group of America to Neutral on Execution Risks and Fully Priced Growth Outlook

Add to Favorite
Added to Favorite


UBS downgraded Reinsurance Group of America (NYSE:RGA) from Buy to Neutral, setting a price target of $216. The downgrade reflects growing concerns that short-term upside may be limited, even as the company aggressively pursues long-term growth.
While UBS acknowledges that RGA’s management is targeting 8–10% annual EPS growth through 2027 by deploying $1.5 billion in capital, this ambitious strategy introduces new layers of execution risk for a company historically recognized for its conservative approach. Much of that deployment — including sidecar partnerships and non-debt financing — is already baked into consensus forecasts, leading analysts to believe near-term returns are largely accounted for.
RGA’s push to capture global reinsurance opportunities is seen as a bold strategic pivot, and UBS doesn’t doubt the company’s ability to hit its targets. However, the reliance on third-party capital and large-scale deals like its recent transaction with EQH could mark a shift from opportunistic growth to growth driven by internal targets, which UBS views as a red flag for risk-conscious investors.
While the long-term fundamentals remain solid, UBS sees the current valuation and the execution demands of RGA’s capital plan as factors that warrant a more cautious stance in the near term.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Lamb Weston Holdings, Inc. (NYSE:LW) Faces Financial Challenges Amid Market Pressures

The consensus price target for Lamb Weston Holdings, Inc....

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Faces Scrutiny Amid Insider Confidence

Leonard Braden Michael, a significant shareholder, purchased 15,209 shares,...

UniFirst Corporation (NYSE: UNF) Earnings Overview

UniFirst Corporation (NYSE: UNF) reported an EPS of $1.32,...

Nanobiotix’s Financial and Developmental Update: A Glimpse into the Future

Earnings per share (EPS) of -$0.58, aligning with estimates,...